Pro-inflammatory mediators (Interleukin-1 beta, Interleukin-6, Interleukin-8, Tumor necrosis factor alpha, Nitric oxide, Inducible nitric oxide synthase, Cyclooxygenase-2)

This entry represents a collection of key pro-inflammatory mediators, including cytokines (Interleukin-1 beta, Interleukin-6, Interleukin-8, Tumor necrosis factor alpha), the signaling molecule nitric oxide, and the enzymes inducible nitric oxide synthase and cyclooxygenase-2. These molecules are central to the orchestration of the innate and adaptive immune responses and are frequently upregulated in chronic inflammatory conditions and various cancers (Source: PubMed, PMID: 10872531). While each component is a distinct biological entity with specific receptors and pathways, they are often studied together as a panel to evaluate the anti-inflammatory potential of therapeutic candidates. Drugs targeting these mediators range from monoclonal antibodies that neutralize specific cytokines to small molecule inhibitors that block enzymatic activity (Source: StatPearls, Rheumatoid Arthritis). Dysregulation of this collective group is a hallmark of diseases such as rheumatoid arthritis, inflammatory bowel disease, and sepsis (Source: UniProt, P01375).

Other names

IL-1β, IL-6, IL-8, TNF-α, NO, iNOS, COX-2Inflammatory markersPro-inflammatory cytokines and enzymesInflammatory mediators

Inhibition of cytokine signaling through ligand neutralization or receptor blockade, and inhibition of enzymatic activity to prevent the synthesis of inflammatory mediators like prostaglandins and nitric oxide.